Identification of a novel benzimidazole that inhibits bacterial biofilm formation in a broad-spectrum manner

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 9, 2011, Pages 4369-4378

  Sambanthamoorthy, Karthik ^a   Gokhale, Ankush A ^b   Lao, Weiwei ^c   Parashar, Vijay ^d   Neiditch, Matthew B ^d   Semmelhack, Martin F ^c   Lee, Ilsoon ^b   Waters, Christopher M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Michigan State University   (United States)

^c PRINCETON UNIVERSITY   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [(4 CHLOROBENCHLOROBENZYL)THIO] 5 METHOXY 1H BENZIMIDAZOLE; 5 METHOXY 2 [(4 METHYLBENZYL)SULFANYL] 1H BENZIMIDAZOLE; BENZIMIDAZOLE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL BIOFILM; BACTERIAL GROWTH; BIOFILM; CONTROLLED STUDY; DISPERSION; DRUG INHIBITION; DRUG STRUCTURE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HIGH THROUGHPUT SCREENING; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIA; BENZIMIDAZOLES; BIOFILMS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 80051809444     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00583-11     Document Type: Article

References (47)

1. Achar, K C, K M Hosamani, and H R Seetharamareddy. 2010. In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives. Eur. J. Med. Chem. 45:2048-2054.
2. Agle, M E, S E Martin, and H P Blaschek. 2005. Survival of Shigella boydii 18 in bean salad. J. Food Prot. 68:838-840. (Pubitemid 40518860)
3. Burse, A., H. Weingar, and M S Ullrich. 2004. NorM, an Erwinia amylovora multidrug efflux pump involved in vitro competition with other epiphytic bacteria. Appl. Environ. Microbiol. 70:693-703. (Pubitemid 38568190)
4. Chan, Y C, and H P Blaschek. 2005. Comparative analysis of Shigella boydii 18 foodborne outbreak isolate and related enteric bacteria: Role of rpoS and adiA in acid stress response. J. Food Prot. 68:521-527. (Pubitemid 40346768)
5. Chung, A J, and M F Rubner. 2002. Methods of loading and releasing low molecular weight cationic molecules in weak polyelectrolyte multilayer films. Langmuir 18:1176-1183. (Pubitemid 35384043)
6. Clatworthy, A E, E. Pierson, and D T Hung. 2007. Targeting virulence: A new paradigm for antimicrobial therapy. Nat. Chem. Biol. 3:541-548. (Pubitemid 47294400)
7. Coetser, S E, and T E Cloete. 2005. Biofouling and biocorrosion in industrial water systems. Crit. Rev. Microbiol. 31:213-232. (Pubitemid 41770020)
8. Costerton, W., et al. 2003. The application of biofilm science to the study and control of chronic bacterial infections. J. Clin. Invest. 112:1466-1477. (Pubitemid 38056271)
9. Evans, R C, and C J Holmes. 1987. Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrob. Agents Chemother. 31:889-894. (Pubitemid 17084045)
10. Fux, C A, J W Costerton, P S Stewart, and P. Stoodley. 2005. Survival strategies of infectious biofilms. Trends Microbiol. 13:34-40. (Pubitemid 40082395)
11. Hall-Stoodley, L., J W Costerton, and P. Stoodley. 2004. Bacterial biofilms: From the natural environment to infectious diseases. Nat. Rev. Microbiol. 2:95-108. (Pubitemid 39490064)
12. Hansen, C R, T. Pressler, and N. Hoiby. 2008. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J. Cyst. Fibros. 7:523-530.
13. Harrison, J J, et al. 2010. Microtiter susceptibility testing of microbes growing on peg lids: A miniaturized biofilm model for high-throughput screening. Nat. Protoc. 5:1236-1254.
14. Hassett, D J, et al. 2009. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol. 17:130-138.
15. Hay, I D, U. Remminghorst, and B H Rehm. 2009. MucR, a novel membrane- associated regulator of alginate biosynthesis in Pseudomonas aeruginosa. Appl. Environ. Microbiol. 75:1110-1120.
16. Hennessy, D R, D N Ali, and S A Tremain. 1994. The partition and fate of soluble and digesta particulate associated oxfendazole and its metabolites in the gastrointestinal tract of sheep. Int. J. Parasitol. 24:327-333. (Pubitemid 24197286)
17. Hoyle, B D, and J W Costerton. 1991. Bacterial resistance to antibiotics: The role of biofilms. Prog. Drug Res. 37:91-105.
18. Jagnow, J, and S. Clegg. 2003. Klebsiella pneumoniae MrkD-mediated biofilm formation on extracellular matrix- and collagen-coated surfaces. Microbiology 149:2397-2405. (Pubitemid 37160715)
19. Jenal, U, and C J Dorman. 2009. Small molecule signaling. Curr. Opin. Microbiol. 12:125-128.
20. Jensen, P O, M. Givskov, T. Bjarnsholt, and C. Moser. 2010. The immune system vs. Pseudomonas aeruginosa biofilms. FEMS Immunol. Med. Microbiol. 59:292-305.
21. Jeys, L, and R. Grimer. 2009. The long-term risks of infection and amputation with limb salvage surgery using endoprostheses. Recent Results Cancer Res. 179:75-84.
22. Kamruzzaman, M., et al. 2010. Quorum-regulated biofilms enhance the development of conditionally viable, environmental Vibrio cholerae. Proc. Natl. Acad. Sci. U. S. A. 107:1588-1593.
23. Kidambi, S., C. Chan, and I S Lee. 2004. Selective depositions on polyelectrolyte multilayers: Self-assembled monolayers of m-dPEG acid as molecular template. J. Am. Chem. Soc. 126:4697-4703. (Pubitemid 38469117)
24. Kim, B S, H. Lee, Y H Min, Z. Poon, and P T Hammond. 2009. Hydrogen- bonded multilayer of pH-responsive polymeric micelles with tannic acid for surface drug delivery. Chem. Commun. 4194-4196.
25. Koczan, J M, M J McGrath, Y. Zhao, and G W Sundin. 2009. Contribution of Erwinia amylovora exopolysaccharides amylovoran and levan to biofilm formation: Implications in pathogenicity. Phytopathology 99:1237-1244.
26. Kolenbrander, P E, R J Palmer, Jr., S. Periasamy, and N S Jakubovics. 2010. Oral multispecies biofilm development and the key role of cell-cell distance. Nat. Rev. Microbiol. 8:471-480.
27. Lauderdale, K J, C L Malone, B R Boles, J. Morcuende, and A R Horswill. 2010. Biofilm dispersal of community-associated methicillin-resistant Staphylococcus aureus on orthopedic implant material. J. Orthop. Res. 28:55-61.
28. Leid, J G, et al. 2005. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J. Immunol. 175:7512-7518. (Pubitemid 41713449)
29. Lipinski, C A, F. Lombardo, B W Dominy, and P J Freeney. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23:3-25. (Pubitemid 27046991)
30. Mah, T F, and G A O'Toole. 2001. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9:34-39.
31. Mehrotra, S., et al. 2010. Time controlled protein release from layer-by-layer assembled multilayer functionalized agarose hydrogels. Adv. Funct. Mater. 20:247-258.
32. Miller, M B, K. Skorupski, D H Lenz, R K Taylor, and B L Bassler. 2002. Parallel quorum sensing systems converge to regulate virulence in Vibrio cholerae. Cell 110:303-314.
33. Nguyen, P T, J D Baldeck, J. Olsson, and R E Marquis. 2005. Antimicrobial actions of benzimidazoles against oral streptococci. Oral Microbiol. Immunol. 20:93-100. (Pubitemid 40364733)
34. Olbe, L., E. Carlsson, and P. Lindberg. 2003. A proton-pump inhibitor expedition: The case histories of omeprazole and esomeprazole. Nat. Rev. Drug Discov. 2:132-139. (Pubitemid 37361645)
35. O'Toole, G A, et al. 1999. Genetic approaches to study of biofilms. Methods Enzymol. 310:91-109. (Pubitemid 29504270)
36. Podschun, R, and U. Ullmann. 1998. Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11:589-603. (Pubitemid 28497563)
37. Rogers, S A, R W Huigens, III, and C. Melander. 2009. A 2-aminobenzimidazole that inhibits and disperses gram-positive biofilms through a zincdependent mechanism. J. Am. Chem. Soc. 131:9868-9869.
38. Sambanthamoorthy, K., A. Schwartz, V. Nagarajan, and M O Elasri. 2008. The role of msa in Staphylococcus aureus biofilm formation. BMC Microbiol. 8:221.
39. Sanyal, P K 2002. Worm control in ruminants in India: prospects of biological control for integrated nematode parasite management. FAO animal production and health paper.Food and Agriculture Organization of the United Nations, Rome, Italy.
40. Shunmugaperumal, T Microbial colonization of medical devices and novel preventive strategies Recent Pat Drug Deliv Formul 4:153-173
41. Sukhishvili, S A 2005. Responsive polymer films and capsules via layer-bylayer assembly. Curr. Opin. Colloid Interface Sci. 10:37-44. (Pubitemid 41149081)
42. Tamayo, R., A D Tischler, and A. Camilli. 2005. The EAL domain protein VieA is a cyclic diguanylate phosphodiesterase. J. Biol. Chem. 280:33324-33330. (Pubitemid 41397129)
43. Van Houdt, R, and C W Michiels. 2010. Biofilm formation and the food industry, a focus on the bacterial outer surface. J. Appl. Microbiol. 109:1117-1131.
44. Wolcott, R D, et al. 2010. Chronic wounds and the medical biofilm paradigm. J. Wound Care 19:45-46, 48-50, 52-53.
45. Yebra, D M, S. Kill, and K. Dam-Johansen. 2004. Antifouling technology - past, present and future steps towards efficient and environmentally friendly antifouling coatings. Progr. Organic Coatings 50:75-104.
46. Zhu, Y F, and J L Shi. 2007. A mesoporous core-shell structure for pH-controlled storage and release of water-soluble drug. Microporous Mesoporous Mater. 103:243-249.
47. Ziebuhr, W. 2001. Staphylococcus aureus and Staphylococcus epidermidis: Emerging pathogens in nosocomial infections. Contrib. Microbiol. 8:102-107.